RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
New Chemical Entities and innovative therapeutic targets
NCEs for innovative therapeutic targets in inflammatory/immunologic diseases. More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Cardiovascular Biomarkers: Players, products and prospects (Volume III)
Aug 2008 - 120 pages - $1,040
CardioVascular BioTherapeutics, Inc. – Product Pipeline Review – Q1 2011
May 2011 - 43 pages - $500
CardioVascular BioTherapeutics, Inc. - Product Pipeline Review - Q4 2010
Nov 2010 - 40 pages - $500
CV & Diabetes Market Forecast
Jan 2009 - $15,200
Hypoactive Sexual Desire Disorder - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Major Depressive Disorder - Pipeline Review, Q1 2011
Feb 2011 - 91 pages - $500
Panic Disorder Therapy Area Pipeline Report
Nov 2010 - 102 pages - $1,495
Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
Feb 2011 - 209 pages - $3,500
Obsessive-Compulsive Disorder Therapy Area Pipeline Report
Nov 2010 - 117 pages - $1,495
Deals and alliances in cardiovascular and circulatory diseases
Jan 2006 - 1126 pages - $2,495
More Related Market Research Reports >>>

Your selection

Industry sector
Drug discovery del
Therapeutic target
Cardiovascular del
Cardiovascular disorder (other) del
Development phase
Early Stage del

Browse By

Industry sector
Bioinformatics
Combinatorial biology
Combinatorial chemistry
Drug research platforms
Genomics
High throughput screening
Proteomics
Therapeutic target
Diabetic cardiovascular disease
Hemorrhoidal
Intermittent claudication
Reperfusion injury
Restenosis
Shock
Ulcer, pressure
Ulcer, venous
Varicose vein

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us